Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogsMaria G Beconi, James R Reed, Yohannes Teffera, et al.Drug Metabolism and Pharmacokinetics|January 6, 2026
Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidanceKenichi Umehara, Andrew Harrell, Chandra Prakash, et al.Iscience|March 16, 2021
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathwayXiaoyuan Lin, Beibei Fu, Songna Yin, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitorsJason M Cox, Bart Harper, Anthony Mastracchio, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humansStella H Vincent, James R Reed, Arthur J Bergman, et al.Bioorganic & Medicinal Chemistry Letters|April 24, 2016
The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitorsJason M Cox, Hong D Chu, Jeffrey T Kuethe, et al.Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitorsScott D Edmondson, Anthony Mastracchio, Jason M Cox, et al.Bioorganic & Medicinal Chemistry Letters|March 12, 2008
Fluoroolefins as amide bond mimics in dipeptidyl peptidase IV inhibitorsScott D Edmondson, Lan Wei, Jinyou Xu, et al.Bioorganic & Medicinal Chemistry Letters|October 28, 2011
Discovery of N-aryl-2-acylindole human glucagon receptor antagonistsChristopher Sinz, Amy Bittner, Ed Brady, et al.ACS Medicinal Chemistry Letters|January 20, 2018
Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein KinaseDanqing Feng, Tesfaye Biftu, F Anthony Romero, et al.Pageof 8